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Chronic cerebral hypoperfusion (CCH) is one of the causes of vascular dementia (VaD) and is
also an etiological factor for Alzheimer’s disease (AD). However, how CCH causes cognitive
impairment and contributes to Alzheimer’s pathology is poorly understood. Here we
produced a mouse model of CCH by unilateral common carotid artery occlusion (UCCAO)
and studied the behavioral changes and brain abnormalities in mice 2.5 months after
UCCAO.We found that CCH caused signiﬁcant short-term memory deﬁcits and mild long-
term spatial memory impairment, as well as decreased level of protein O-GlcNAcylation,
increased level of tau phosphorylation, dysregulated synaptic proteins and insulin signaling,
and selective neurodegeneration in the brain. These ﬁndings provide mechanistic insight
into the effects of CCH on memory and cognition and the likely link between AD and VaD.
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INTRODUCTION
Vascular dementia (VaD) is the second most common form
of dementia after Alzheimer’s disease (AD) in older adults
(Battistin and Cagnin, 2010), accounting for ∼20% of all demen-
tia cases worldwide (Dubois and Hébert, 2001). VaD is deﬁned
as the loss of cognitive function to a degree that interferes daily
living activities caused by problems in blood supply to the brain,
which injures brain regions important for memory, cognition, and
behavior (Roman, 2002). Chronic cerebral hypoperfusion (CCH)
is a major cause of VaD and can result from disorders that affect
cerebral vascular system, including hypertension, diabetes, gen-
eralized atherosclerosis, and smoking (Meyer et al., 2000; Valerio
Romanini et al., 2013). Individuals with CCH usually have cog-
nitive deﬁcits to various degrees. The important role of CCH
in dementia has already immerged to the front edge of neurol-
ogy research. Studies in the last decade have suggested that CCH
might promote neurodegeneration through neuronal energy fail-
ure, production of reactive oxygen species and proinﬂammatory
cytokines by activated microglial cells that, in turn, damage the
neuronal cells, and contribute to white matter lesions (Kitagawa
et al., 2005; Farkas et al., 2007; Adibhatla andHatcher, 2008; Urabe,
2012; Bang et al., 2013).
Cerebral vascular abnormalities are also an important con-
tributing factor for AD (Kalaria et al., 2012; Leszek et al., 2012;
Sato and Morishita, 2013; Sudduth et al., 2013). It is estimated
that as many as 40% of AD patients actually have a mixed demen-
tia of AD and VaD (Kammoun et al., 2000). AD is characterized
by chronic and progressive neurodegeneration leading to progres-
sive cognitive dysfunction and eventually to death of the patients.
AD in most cases is sporadic and is probably caused by multiple
factors. AD is histopathologically characterized by the presence of
both intraneuronal neuroﬁbrillary tangles (NTFs) and extracellu-
lar senile plaques together with neuroﬁbrillary degeneration in the
brain. NFTs are predominantly comprised of aggregated abnor-
mally hyperphosphorylated tau (Grundke-Iqbal et al., 1986a,b),
whereas senile plaques are made of aggregated amyloid-β (Aβ)
peptides. We have previously found that impaired brain glucose
metabolism in AD probably lead to abnormal hyperphosphoryla-
tion of tau and neuroﬁbrillary degeneration via down-regulation
of tau O-GlcNAcylation, a post-translational modiﬁcation of pro-
teins with β-N-acetylglucosamine (GlcNAc; Liu et al., 2004, 2009).
Thus, we postulate that CCH might lead to chronic neurode-
generation and cognitive impairment in AD and VaD through
reduction of cerebral glucosemetabolism and consequently down-
regulation of O-GlcNAcylation and hyperphosphorylation of tau.
The present study was aimed to test this hypothesis in a mouse
model of CCH.
A common rodent model of CCH is produced by unilat-
eral common carotid artery occlusion (UCCAO; Levine, 1960;
Rice et al., 1981). A 35–55% decrease of cerebrocortical perfu-
sion is reported in the ipsilateral hemisphere in mice 28 days
after UCCAO surgery (Kitagawa et al., 2005). To investigate
the role of CCH in AD-related brain abnormalities and cog-
nitive impairment, we performed UCCAO in adult mice and
then studied general and memory behavior, O-GlcNAcylation,
tau phosphorylation, synaptic proteins, hexosamine biosynthetic
pathway (HBP) and insulin signaling. We found that CCH caused
anxiety and deﬁcits of motor functions and spatial memory,
led to a decrease in O-GlcNAcylation and an increase in tau
phosphorylation, dysregulated synaptic proteins, and resulted in
alterations of the HBP and insulin signaling pathway in the mouse
brains.
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MATERIALS AND METHODS
ANTIBODIES AND REAGENTS
Primary antibodies used in this study are listed in Table 1.
Peroxidase-conjugated anti-mouse and anti-rabbit IgG were
obtained from Jackson ImmunoResearch Laboratories (West
Grove, PA,USA). The enhanced chemiluminescence (ECL) kit was
from Pierce (Rockford, IL, USA). Avidin-biotin complex (ABC)
staining system was from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Other chemicals were from Sigma (St. Louis, MO,
USA).
ANIMALS AND UCCAO
Breeding pairs of mice (B6.129) were originally obtained from the
Jackson Laboratory (New Harbor, ME, USA), and the mice were
bred at our institutional animal colony. They were housed (4∼5
animals per cage) with a 12/12 h light/dark cycle and with ad
libitum access to food and water. The housing, breeding, and ani-
mal experiments were in accordance with the approved protocol
from our Institutional Animal Care and Use Committee and with
the PHS Policy on Human Care and Use of Laboratory animals
(revised March 15, 2010).
Male mice of 4.5–6 months old were randomly divided into
two groups. The CCH group mice (n = 10) were subjected to
unilateral (right side) common carotid artery (CCA) occlusion,
and the control mice (n = 12) underwent the same proce-
dure without vessel occlusion (sham surgery). The UCCAO was
performed by permanent vessel double ligation under general
anesthesia with 2.5% avertin. Brieﬂy, a ventral midline incision
was made to expose the right CCA. The artery was gently iso-
lated from the carotid sheath and vagus nerve and the right
CCA was doubly ligated with 9-0 silk suture (Ethicon®) just
below the bifurcation. The midline incision was then closed care-
fully, and the animals were transferred back into their cages with
free access to water and food. One month after the surgery,
the mice were subjected to a battery of behavioral tests which
lasted for 6 weeks (Figure 1A). After surgery, the body weight
and food intake were monitored weekly. After completion of
all behavioral tests, the mice were sacriﬁced by decapitation
2.5 months after the surgery, and the brains were removed imme-
diately. The cerebral cortex and the hippocampus of the right
hemispheres of the sham mice and of both hemispheres of the
UCCAO mice were dissected, ﬂash frozen in dry ice, and stored
in –80◦C for biochemical analyses. Some brains were ﬁxed with
4% paraformaldehyde in 0.1 M PBS, followed by cryoprotec-
tion in 30 % sucrose. Coronal sections (40 μm thick) were
cut on a freezing microtome. The sections were stored in gly-
col anti-freeze solution (ethylene glycol, glycerol, and 0.1 M
PBS in a 3:3:4 ratio) at −20◦C until immunohistochemical
staining.
BEHAVIORAL TESTS
All behavioral tests were performed between 8:00 a.m. and
5:00 p.m. Before the behavioral tests started, the mice were
habituated by being handled by experimenters. Before each
test, mice were transported to the test room (temperature was
23 ± 1◦C) located inside of the animal colony to acclimatize
for 1 h.
Open ﬁeld
Exploratory activity, anxiety and locomotor activity were mea-
sured using the open ﬁeld test. The apparatus was constructed
of white painted plywood measured 50 cm × 50 cm as the square
arena and 40 cmhighPVCwalls. A central square of 20 cm× 20 cm
was surmounted by an automated camera-based video tracking
system (ANY-Maze version 4.5 software; StoeltingCo.,WoodDale,
IL, USA). Each mouse was placed individually in the arena and
allowed to explore for 15 min, and the overall performance includ-
ing distance traveled, distance in central area, central area entries
and time spent in central area were recorded by the video tracking
system. After the 15 min test, mice were returned in their home
cages. Between test of each mouse, all urines and defecations were
cleared from the ﬁeld, followed by cleaning with 70% ethyl alcohol
and air drying of the ﬁeld.
Elevated plus maze
Elevated plus maze measures anxiety induced by open spaces, as
well as height related anxiety (Walf and Frye, 2007). The appa-
ratus was an elevated (80 cm high) maze consisting of four arms
(30 cm × 5 cm each) connected by a common 5 cm × 5 cm cen-
tral area making the shape of a plus sign. Two of the arms facing
opposite were enclosed by 20 cm-high walls and were thus called
closed arm (CA), whereas the other two facing arms were open
and were thus called open arm (OA). Each mouse was placed onto
the central area facing an OA and allowed to explore the maze for
8min. The automatic video tracking systemwas used for collecting
behavioral data including the number of CA entries, OA entries,
and time spent in CA and OA. Between test of each mouse, the
maze ﬂoor was cleaned as described above for the open ﬁeld.
Novel object recognition
Mice have a tendency to interact more with a novel object than
with a familiar one. This tendency has been used by behav-
ioral pharmacologists and neuroscientists to study learning and
memory. A popular protocol for such research is the object
recognition task (Bevins and Besheer, 2006). The test appara-
tus was the same one as used in the open ﬁeld test described
above. The procedure consisted of three phases: habituation
phase, sample phase, and test phase. During habituation phase,
each mouse was allowed to explore the ﬁeld in the absence of
objects for 15 min for four consecutive days in order to make
the mice become familiar with the ﬁeld. On the ﬁfth day dur-
ing the sample phase, two objects were placed symmetrically
onto the arena. The mouse was placed at the mid-point of the
wall opposite the sample objects with its body parallel to the
side walls and its nose pointing away from the objects, allowed
to freely explore for 5 min. Time spent exploring the objects
was recorded. During the test phase, one of the two objects
used in sample phase was randomly replaced by a novel one,
the mouse was reintroduced to the arena for 5 min explo-
ration after a 15 min delay. Another 5 min test session was
performed 24 h later for evaluation of long-term memory reten-
tion (Ennaceur and Delacour, 1988). Between each mouse, any
feces were cleared, and the arena and objects were cleaned with
70% ethyl alcohol. The video tracking system was used to col-
lect behavioral performances automatically. Time spent exploring
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Table 1 | Primary antibodies used in this study.
Antibody Type Specificity Phosphorylation sites Source/Reference
HIF-1β Mono- HIF-1β Abcam, Cambridge, MA, USA
TIGAR Poly- TIGAR Abcam
GLUT1 Poly- GLUT1 Millipore, Temecula, CA, USA
GLUT2 Poly- GLUT2 Milipore, Billerica, MA, USA
GLUT3 Poly- GLUT3 Santa Cruz Biotech., Santa Cruz, CA, USA
OGT Poly- OGT Sigma, St. Lious, MO, USA
OGA Poly- OGA Crawford et al. (2008)
CTD110.6 Mono- O-GlcNAc Covance, Emeryville, CA, USA
RL2 Mono- O-GlcNAc Afﬁnity Bioreagents, Golden, CO, USA
pS199 Poly- P-tau Ser199 Invitrogen, Grand Island, NY, USA
pT205 Poly- P-tau Thr205 Invitrogen
pT212 Poly- P-tau Thr212 Invitrogen
pS214 Poly- P-tau Ser214 Invitrogen
pT231 Poly- P-tau Thr231 Invitrogen
pS262 Poly- P-tau Ser262 Invitrogen
pS396 Poly- P-tau Ser396 Invitrogen
pS404 Poly- P-tau Ser404 Invitrogen
R134d Poly- Tau Tatebayashi et al. (1999)
Synapsin1 Poly- Synapsin 1 Santa Cruz Biotech.
Synaptophysin Mono- Synaptophysin Millipore
PSD95 Mono- PSD95 Cell Signaling Tech, Danvers, MA, USA
GFAT2 Poly- GFAT2 Santa Cruz Biotech.
IRβ Poly- IRβ Cell signaling Technology, Danvers, MA, USA
IGF-1Rβ Poly- IGF-1Rβ Cell signaling Technology
P-IRβ/IGF-1Rβ Mono- P-IRβ/IGF-1Rβ Tyr1150/1151(IRβ), Tyr1135/1136 (IGF-1Rβ) Cell signaling Technology
IRS1 Poly- IRS1 Cell Signaling Technology
IRS1 pS307 Poly- P-IRS1 Ser307 Cell Signaling Technology
PI3K p85 Poly- PI3K (p85) Cell Signaling Technology
P-PI3K p85 Poly- P-PI3K (p85) Tyr458/Tyr199 Cell Signaling Technology
PDK1 Poly- PDK1 Cell Signaling Technology
PDK1 pS241 Poly- P-PDK1 Ser241 Cell Signaling Technology
AKT Poly- AKT Cell Signaling Technology
AKT pS473 Poly- P-AKT Ser473 Cell Signaling Technology
GSK-3β Poly- GSK-3β Cell Signaling Technology
GSK-3β pS9 Poly- P-GSK-3β Ser9 Cell Signaling Technology
GAPDH Poly- GAPDH Santa Cruz Biotech.
both the novel and the familiar objects was recorded (TN , TF).
Object discriminationwas evaluated by the recognition index (RI):
RI = TN /(TN + TF).
Accelerating Rotarod test
Motor coordination and motor learning of mice were assessed by
using Rotarod test. The mouse was placed on the roller lane of
the Rotarod (Panlab, LE8500, Spain) and started rotating the rod
with a steady acceleration from 4 to 40 rpm over a 5 min period.
The latency at which the mouse fell off the rod was recorded. Each
mouse was given six trials with 10–15 min inter-trial intervals
(ITIs).
Forced swim test
Depression-like behaviors were evaluated through forced swim
test. A transparent plastic beaker (17 cm in diameter × 24 cm
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FIGURE 1 | Animal study design (A) and verification of the UCCAO model
(B,C). Homogenates of the cortices and hippocampi of mice 2.5 months after
sham or UCCAO surgery were analyzed byWestern blots developed with the
indicated antibodies (B). Each lane represents an individual mouse sample.
The blots were then quantiﬁed densitometrically, and the data after
normalization with the GAPDH level are presented as mean ± SEM
(n = 6/group), where the values of the sham group are set as 1.0 (C).
*p < 0.05 vs. sham group; #p < 0.05 vs. contralateral group.
high) containing water (23 ± 1◦C) to a depth of 17 cm was used
as the swimming apparatus. All mice were individually forced to
swim for 6 min, and the duration of immobility was observed and
measured during the ﬁnal 4 min of the test. Immobility consists
of the mouse ﬂoating in the water without struggling and only
making movements necessary to keep its head above water surface
(Slattery and Cryan, 2012).
Footprint test
Motor coordination and gait were assessed through footprint test
using a 50 cm long and 8 cm wide runway (with 10 cm high
walls). Before collecting the footprints, each mouse was trained
for three or four runs to make sure it was able to run along
the runway at a steady pace and in a straight line without wan-
dering. To obtain footprints, the forepaws and hindpaws of the
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mice were respectively coated with red and blue non-toxic paints.
To collect the footprints, a fresh sheet of pale white paper was
placed on the ﬂoor of the runway for each run. The footprint
patterns were analyzed for the following four step parameters
(all measured in centimeters). (1) Stride length was measured as
the average distance of forward movement between each stride.
The left/right forelimb and left/right hindlimb stride were also
measured separately. (2) Front/hind base width was measured
as the average distance between left and right front/hind foot-
prints, respectively. These values were determined by measuring
the perpendicular distance of a given step to a line connect-
ing its opposite preceding and proceeding steps. (3) Overlap
between forepaw/hindpaw placements were measured as the dis-
tance between the front/hind footprints on each side. When
the center of the hind footprint fell on top of the center of
the preceding front footprint, a value of zero was recorded
(Carter et al., 1999).
Morris water maze
Morris water maze (MWM) was used to evaluate spatial learn-
ing and memory of the mice (D’Hooge and De Deyn, 2001). The
test was performed in a circular white pool (with a diameter of
180 cm and a height of 60 cm) ﬁlled with white dye tinted water
and maintained at room temperature (20 ± 1◦C). The maze was
designated of two principal axes with each line bisecting the maze
perpendicular to the other one to divide the maze into four equal
quadrants. The end of each line demarcates four cardinal points:
north (N), south (S), east (E), and west (W). A platform was posi-
tioned in the middle of one of the quadrants submerged 1 cm
below water surface. Each mouse performed four trials per day for
four consecutive days from semi-random start positions (Table 2)
to ﬁnd the hidden platform. Each trial was terminated as soon as
the mouse climbed onto the hidden platform. If a mouse failed to
ﬁnd the platform within 90 s, it was gently guided to it. At the end
of each trial, the mouse was left on the platform during a 20 s ITI,
Table 2 | Mouse start positions in the Morris water maze.
Day Trial 1 Trial 2 Trial 3 Trial 4
Original tests
1 S NW SE W
2 NW W S SE
3 W SE NW S
4 SE S W NW
Probe NE
platform site location: SW
Reversal tests
1 N E SW NW
2 SE N NW W
3 NW SW W N
4 E NW N SE
Probe SW
platform site location: NE
then dried and returned to its home cage. A 60 s probe test without
platform was performed 24 h after the last trial. The swim path,
swim distance (cm), escape latency (sec), swim speed (cm/sec),
time spent in each quadrant (sec), distance traveled in each quad-
rant (cm), latency to enter the platform site zone (sec), and the
number of platform site zone crossings were recorded through an
automated tracking system (Smart video tracking system, Panlab;
Havard Apparatus). A reversal test was performed on the day after
the probe day of original test. For the reversal test, all conditions
were the same as the original test except the platform was relo-
cated to the center of the opposite quadrant against the original
one.
WESTERN BLOT ANALYSIS
Mouse brain tissue was homogenized in pre-chilled buffer con-
taining 50 mM Tris-HCl (pH 7.4), 50 mM GlcNAc (inhibitor
of O-GlcNAcase that catalyzes the removal of O-GlcNAc from
a protein), 20 μM UDP (inhibitor of O-GlcNAc transferase),
2.0 mM EGTA, 2 mM Na3VO4, 50 mM NaF, 0.5 mM AEBSF,
10 μg/ml aprotinin, 10 μg/ml leupeptin, and 4 μg/ml pepstatin
A. Protein concentrations of the homogenates were determined
by using PierceTM 660 nm Protein Assay kit (Thermo Fisher Sci-
entiﬁc Inc.). The samples were resolved in 10% or 12.5% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and electro-transferred onto Immobilon-P membrane (Millipore,
Bedford, MA, USA). The blots were then probed with pri-
mary antibody (Table 1) and developed with the corresponding
horseradish peroxidase–conjugated secondary antibody and ECL
kit (Pierce, Rockford, IL, USA). Densitometrical quantiﬁcation of
protein bands in Western blots were analyzed by using the Multi
Gauge V3.0 software (Fuji Photo Film Co., Ltd).
IMMUNO-DOT-BLOT ASSAY
The level of O-GlcNAcylation in the brain homogenates was
determined by using a quantitative immuno-dot-blot assay (Liu
et al., 2002) with modiﬁcations. Brieﬂy, homogenate samples
were ﬁrst dissolved in Laemmli buffer and then diluted with
the homogenizing buffer till the SDS concentration was 0.05%
or lower. The diluted samples were dotted onto nitrocellulose
membrane (Schleicher and Schuell, Keene, NH, USA) at 6 ul
per grid of 6 × 6 mm in size. The blots were placed in a 37◦C
oven for 0.5–1 h to allow the protein binding to the mem-
brane. After the membrane was blocked with TBST (10 mM
Tris-HCl, pH7.5, 150 mM NaCl, 0.3% Tween-20) for 1 h,
the blots were overlaid with a mixture of antibodies RL-2 and
CTD110.6 and then incubated at 4◦C overnight. After washing
withTBST, the blotswere processed as described above forWestern
blots.
IMMUNOHISTOCHEMICAL STAINING
Floating sagittal sections were incubated at room temperature
in 0.3% H2O2 for 30 min and then in 0.3% Triton X-100 for
15 min, washed in PBS, and blocked in a solution containing 5%
normal goat serum and 0.1% Triton X-100 for 30 min. Sections
were then incubated at 4◦C with primary antibody overnight, fol-
lowed by development with biotinylated secondary antibody and
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avidin/biotinylated horseradish peroxidase (Santa Cruz Biotech-
nology). The sections were stained with peroxidase substrate and
then mounted on microscope slides (Brain Research Laboratories,
Newton, MA, USA), dehydrated, and covered with coverslips.
FLUORO-JADE STAINING
Floating sagittal sections were mounted on gelatin coated slide,
dried at room temperature overnight, and then rinsed in distilled
water for 1 min. After incubation in freshly prepared 0.06% potas-
sium permanganate for 10 min and washes with distilled water,
sections were stained with 0.0004% Fluoro-Jade B in 0.09% acetic
acid for 10 min. After washes again, the sections were further
stained with DAPI. Stained sections were observed under a ﬂuo-
rescence microscope (PCM2000, Nikon, Melville, NY, USA), and
positive cells were counted under 20 × magniﬁcation by the use
of Image J software (National Institutes of Health).
STATISTICAL ANALYSIS
For behavioral tests, data were analyzed by two-way ANOVA
or unpaired two-tailed t-test using Graphpad Prism 5s. For
biochemical analyses, data were analyzed by one-way ANOVA
followed by Tukey’s post hoc tests or unpaired two-tailed t-
tests, using Graphpad Prism 5. All data are presented as
means ± SEM, and p < 0.05 was considered statistically
signiﬁcant.
RESULTS
VERIFICATION OF THE CCH MODEL
Previous studies have demonstrated that UCCAO does not pro-
duce histologically detectable cerebral ischemia or neuronal cell
death (Kitagawa et al., 2005; Lee et al., 2011; Pimentel-Coelho
et al., 2013). Thus, we ﬁrst veriﬁed the success of UCCAO by
detecting the levels of hypoxia inducible factor-1β (HIF-1β), TP53-
induced glycolysis and apoptosis regulator (TIGAR) and glucose
transporters (GLUTs) 1 and 3, because the expression of these
proteins increases during cerebral or cardiac ischemia (Watan-
abe et al., 2009; Kimata et al., 2010; Chan et al., 2011; Iwabuchi
and Kawahara, 2011; Yan et al., 2011; Yuan et al., 2011; Hoshino
et al., 2012;Wang et al., 2012a,b). As expected,we found signiﬁcant
increases in the levels of these proteins in both the cerebral cortex
and the hippocampus of the ipsilateral side of the UCCAO mice
(Figures 1B,C). A trend of increase inGLUT1 andGLUT3was also
seen in the contralateral side, and this increase reached statistical
signiﬁcance for cerebrocortical GLUT1 (Figure 1C), which might
suggest that there was mild chronic hypoperfusion at the con-
tralateral hemisphere in the mice 2.5 months after UCCAO. As a
negative control, the level of GLUT2 was not altered after UCCAO
(Figures 1B,C). These results showed the success of CCH in the
brains of mice after UCCAO.
CCH CAUSES ANXIETY AND DEFICITS OF MOTOR FUNCTIONS
To investigate the effects of CCH on the mouse behavior, we ﬁrst
monitored general conditions of the mice, including body weight
and food intake after sham or CCH surgery. We found that the
body weights of both groups decreased one week after the surgery
(Figure 2A), indicating the consequence of stress from the surgery
itself on the mice. The body weight recovered a week later, but
the CCH mice constantly had a signiﬁcantly higher body weights
(5–6% higher) than the sham mice. Interestingly, the CCH mice
had a much lower food intake (∼20% lower) than the sham mice
after the marked decline during the ﬁrst week after the surgery
(Figure 2B). The surprising opposite changes of the body weight
and food intake of the CCH mice suggest that CCH might have
caused decreased metabolism and/or activity in mice.
We then assessed the general behaviors including exploratory
activity, anxiety, and locomotor activity of the mice. By testing
the mice in an open ﬁeld, we found that the CCH mice traveled a
shorter distance (Figure 2C) and spent less time (data not shown)
in the central area of the open ﬁeld than the sham mice. In an
elevated plus maze for measuring open space- and height-induced
anxiety, we found that the CCH mice entered the CAs more fre-
quently (Figure 2D). Together, these results suggest an increased
level of anxiety and a decreased level of spontaneous exploratory
activity of the CCH mice, the latter of which is consistent with
the increased body weights and decreased food intake of the CCH
mice observed above.
To study whether UCCAO changes the gait and motor coor-
dination of the mice, we carried out foot print test and Rotarod
test. We found that the left forelimb stride of the CCH mice was
slightly shorter than that of the shammice asmeasured in the foot-
print test (Figure 2E). However, the decrease in the left forelimb
stride of the CCH mice was not statistically signiﬁcant as com-
pared to the right forelimb stride of the same mice. The Rotarod
test showed marked decrease of the fall latency of the CCH mice
as compared to the sham group (Figure 2F). These results indicate
that theCCHmicemight have a slight decrease inmotor activity of
left side (contralateral side) and a pronounced decrease in motor
coordination and motor learning. However, forced swim test did
not show any detectable abnormality in swimming, nor the time
spent immobile in the CCH mice (Figure 2G), indicating that the
CCH mice were not under a depressive state.
CCH LEADS TO MILD IMPAIRMENT IN MEMORY
The non-spatial working memory related to frontal subcortical
circuits of the mice was assessed by using object recognition test
(Sarti et al., 2002) with 15 min and 24 h intervals between the
sample phase and the test phase. During the sample phase, all
mice spent the same amount of time in exploring both objects
(Figure 2H). However, the CCH mice spent less time exploring
the novel object than the sham mice when tested both 15 min
and 24 h after the sample phase, although the decrease only at the
15 min time point reached the statistical signiﬁcance (Figure 2I).
These results indicate a short-term memory deﬁcit in the CCH
mice.
We also employed MWM to investigate the long-term spatial
reference learning andmemory of thesemice.We observed a slight
but signiﬁcant decrease in swim speed of the CCH mice during
the training phase (Figure 3A), which is consistent with the deﬁcit
in locomotor activity of these mice, as detected above. During
the training phase in the water maze, both groups showed proper
learning as evidenced by continuous decrease in the distance trav-
eled (Figure 3B) and the latency (data not shown) to locate the
hidden escape platform. Retrieval of spatial memory was more
speciﬁcally tested with the probe trial performed 24 h after the last
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FIGURE 2 | General behavior and short-term memory of mice with CCH.
The body weight and food intake were monitored once a week after sham or
UCCAO surgery (A,B). Spontaneous locomotor and exploratory activity was
assessed in an open ﬁeld (C). Anxiety-like behaviors were evaluated in an
elevated plus maze, and the CAs entries are shown (D). Gait was evaluated
using footprint test, and different limb strides are shown (E). Motor
coordination and balance were evaluated using accelerating Rotarod, and the
fall latency of each trial is shown (F). Depression was evaluated using forced
swim test, and last 4 min immobility out of total 6 min is shown (G). One-trial
object recognition task was carried out in an open ﬁeld. Time spent exploring
two identical objects during sample phase are shown as percentage of object
exploring time (H). Object discrimination during test phase is presented by
the recognition index (time exploring the novel object/total time for
exploring) (I). Data are reported as mean ± SEM.*p < 0.05 vs. sham mice.
training trial. Memoryperformanceof themicewasdeterminedby
the number of the former platform site crossings and the percent-
age of time/distance animals spent/traveled in the target quadrant.
We found that the CCH mice showed a decrease in the number of
platform crossings (Figure 3C), a slight increase of the latency to
ﬁrst crossing (data not shown), and slightly less preference toward
the target quadrant (Figure 3D). However, none of these changes
observed in the CCH mice reached a statistical difference. These
results suggest that the CCH mice did not have a deﬁcit in spatial
memory or the tests and/or the sample size we used did not have
sufﬁcient power to detect the mild deﬁcit of spatial memory in the
CCH mice.
In an attempt to increase the sensitivity of the spatial mem-
ory test, we further carried out ﬁve days’ reversal test in the MWM
starting on the next day following the probe test of the original test.
For the reversal test, the escape platformwas relocated to the quad-
rant opposite to the original quadrant. We observed that the CCH
mice again had a lower swim speed (Figure 3E), a marked decrease
in the mean platform site crossing (Figure 3G) and slightly less
preference toward the target quadrant (Figure 3H) at the probe
trial of the reversal test. However, these changes did not reach sta-
tistical signiﬁcance, apparently due to large scattering of the data.
The training curve of the reversal test indicated that the CCH mice
traveled a shorter distance (Figure 3F) and had a shorter latency
(data not shown) to locate the new hidden escape platform dur-
ing the ﬁrst three days of the training phase. To learn if this was
because the CCH mice remembered the previous escape less well
than the sham mice, we analyzed the distance traveled and the
time spent in the quadrant where the previous old hidden escape
platform was located. We found that the CCH mice traveled a
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FIGURE 3 | Morris water maze tests of mice with CCH. Spatial memory of
the mice was tested in the Morris water maze test (A–D) and the consecutive
reversal test (E–L). The average swim speed in the training phase (A,E), the
distance traveled to the hidden platform during training (B,F), the number of
the platform site crossings during the probe trial (C,G), the percentage of
distance traveled in the target, adjacent left (Adj.L), adjacent right (Adj.R), and
opposite (Opp) quadrants during probe trial (D,H) and the gradual reduction in
percent time/distance in the quadrant of previous platform and the gradual
shift to the new quadrant (I–L) are shown. Data are reported as
mean ± SEM.*p < 0.05 vs. sham mice.
shorter distance (Figure 3I) and spent shorter time (Figure 3J) in
that quadrant than the sham mice, suggesting that the apparently
better performance of the CCH mice during the ﬁrst three days’
training in the reversal water maze, as seen in Figure 3F, was actu-
ally because these mice remembered the old platform location less
well than the sham mice. The CCH and the sham mice showed
no difference in the distance traveled (Figure 3K) and the time
spent (Figure 3L) in the quadrant where the new escape platform
was located during the training phase of the reversal water maze
test, again suggesting no learning deﬁcit of the CCH mice. Taken
together, these results suggest that the CCH mice had no impair-
ment in learning, but had a slight impairment in long-term spatial
memory.
CCH LEADS TO DECREASED O-GLCNACYLATION AND INCREASED TAU
PHOSPHORYLATION
Because CCH is expected to reduce brain glucose metabolism and
O-GlcNAcylation is a sensor of intracellular glucose metabolism
(Zachara and Hart, 2004) and regulates tau phosphorylation
negatively (Liu et al., 2004, 2009; Li et al., 2006), we inves-
tigated protein O-GlcNAcylation and its regulating enzymes
O-GlcNAc transferase (OGT, which adds GlcNAc groups to pro-
teins) and O-GlcNAcase (OGA, which removes GlcNAc from
proteins), as well as tau phosphorylation. We found a signif-
icant decrease in the O-GlcNAcylation level in both the cor-
tex and the hippocampus of the ipsilateral side of the CCH
mice, as determined by immuno-dot blots developed with a
mixture of two monoclonal antibodies both against various O-
GlcNAcylated proteins (Figures 4A,B). To uncover the underlying
mechanism for the change of O-GlcNAcylation, we determined
OGT and OGA levels by Western blots and observed signiﬁ-
cant decrease in the OGT level in the hippocampus of the CCH
mice (Figures 4A,B), which might partially explain the decreased
O-GlcNAcylation.
Site-speciﬁc tau phosphorylation in the mouse brains
was determined by Western blot developed with several
phosphorylation-dependent and site-speciﬁc tau antibodies, and
the total tau by a polyclonal pan-tau antibody R134d. We found
that tau phosphorylation increased markedly at most of the phos-
phorylation sites studied in the hippocampus and at Thr212 and
Ser262 of the cortex of the CCH mice (Figures 4C,D), which is
consistent with the decrease of O-GlcNAcylation. Surprisingly, the
increased tau phosphorylation was also seen at the contralateral
side, where O-GlcNAcylation was not found to be decreased, of
the UCCAO mice, suggesting that additional mechanism might
be involved in tau phosphorylation at the contralateral side of the
UCCAO mice.
CCH DYSREGULATES SYNAPTIC PROTEINS
Synapses are the structural basis of memory and cognition, which
depends on synaptic plasticity that is in turn regulated by modu-
lation of neurotransmitter release from the pre-synaptic site and
of the number, types and properties of neurotransmitter recep-
tors at the post-synaptic site. To understand the molecular basis
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FIGURE 4 | Effects of CCH on O-GlcNAcylation and tau
phosphorylation. Homogenates of the cortices and hippocampi of mice
2.5 months after sham or UCCAO surgery were analyzed by immuno-dot
blots developed with a mixture of monoclonal antibodies RL2 and
CTD110.6 against O-GlcNAcylated proteins and Western blots developed
with the indicated antibodies (A,C). The blots were then quantiﬁed
densitometrically, and the data after normalization with the GAPDH (B)
or R134d for total tau level (D) are presented as mean ± SEM
(n = 6/group), where the values of the sham group are set as
1.0.*p < 0.05 vs. sham group.
of the mild memory impairment we detected in the CCH mice,
we determined the levels of major pre- and post-synaptic proteins
in the mouse brains. We found a dramatic increase in the level of
synapsin but marked decrease in synaptophysin, both of which are
commonly used as pre-synaptic markers, in both the cerebral cor-
tex and the hippocampus of the CCH mice (Figures 5A,B). The
level of post-synaptic density 95 (PSD95), a post-synaptic marker,
was also found to be increased in the cerebral cortex of the CCH
mice. These results indicate a dysregulation of synaptic proteins in
the brains of the CCH mice. Interestingly, the contralateral side of
the CCH mice tended to have the similar dysregulation of synaptic
proteins, implicating that milder but similar changes might occur
at the contralateral side of the CCH mice.
We also carried out immunohistochemical studies of synapto-
physin in the mouse brains. The decreased immunostaining was
seen throughout the cerebral cortex and various sectors of the
hippocampus, more apparent in the ipsilateral side (Figure 5C).
These results are consistent with the results from Western blots.
CCH AFFECTS THE HBP AND INSULIN SIGNALING PATHWAY IN THE
BRAIN
A small fraction of intracellular glucose is metabolized into
uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), the
donor of protein O-GlcNAcylation, through the HBP, and
OGT activity is dependent on intracellular UDP-GlcNAc level
(Hanover et al., 2010). The rate limiting enzyme of the HBP is
L-glutamine:fructose-6-phosphate amidotransferase (GFAT). As
we had observed a decreased level of O-GlcNAcylation after CCH,
we further investigated the level of GFAT2, the major isoform of
GFAT in themammalianbrain, and found that theGFAT2 levelwas
increased in the ipsilateral hippocampus, but not in the cerebral
cortex, of the CCH mice (Figures 6A,B).
Glucosemetabolism aswell as neural plasticity andmemory are
modulated by insulin signaling (Gerozissis, 2008; Cardoso et al.,
2009), which is deregulated in AD brain (Liu et al., 2011). The
classical insulin signaling pathway includes insulin receptor (IR),
insulin-like growth factor-1 receptor (IGF-1R), insulin receptor
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FIGURE 5 | Effects of CCH on synaptic proteins. Homogenates of the
cortices and hippocampi of mice 2.5 months after sham or UCCAO
surgery were analyzed by Western blots developed with the indicated
antibodies (A). The blots were then quantiﬁed densitometrically, and the
data after normalization with the GAPDH level are presented as
mean ± SEM (n = 6/group), where the values of the sham group are
set as 1.0 (B).*p < 0.05 vs. sham group. #p < 0.05 vs. contralateral
group. The coronal brain sections were immunostained with antibody
against synaptophysin (C). CA, Cornu Ammonis; DG, dentate gyrus;
Scale bar: 100 μm.
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FIGURE 6 | Effects of CCH on the GFAT2 and the insulin signaling
pathway. Homogenates of the cortices and hippocampi of mice 2.5 months
after sham or UCCAO surgery were analyzed byWestern blots developed
with the indicated antibodies (A). The blots were then quantiﬁed
densitometrically, and the data after normalization with the GAPDH (B) or the
corresponding protein level (C) are presented as mean ± SEM (n = 6/group),
where the values of the sham group are set as 1.0; *p < 0.05 vs. sham group.
#p < 0.05 vs. contralateral group.
substrate-1 (IRS-1), phosphatidylinositide 3-kinases (PI3K), 3-
phosphoinositide-dependent protein kinase-1 (PDK1), protein
kinase B (AKT), and glycogen synthase kinase-3 (GSK-3). This
signaling is activated through the phosphorylation of each com-
ponent by its upstream component of the signaling cascade.
We therefore studied the brain insulin signaling by determin-
ing the level and activation status of each component of the
insulin signaling pathway in the brain by quantitative western
blots. The activation status was estimated by determining the
level of phosphorylation, which reﬂects the enzymatic activity,
with the phosphorylation-dependent antibodies. We observed
changes of the level and/or phosphorylation of several compo-
nents of the insulin signaling pathway in the ipsilateral side of
the brains of UCCAO mice (Figure 6). These changes included
increases in the levels of IGF-1Rβ, the p85 subunit of PI3K and its
phosphorylation, PDK1 and its phosphorylation, and the phos-
phorylation of AKT and GSK-3β, as well as decreases in the levels
of IR-β and IRS1 phosphorylation in the hippocampus. In case
of the levels of IR-β, IRS1 and the phosphorylation of PI3K
p85, AKT, and GSK-3β, the UCCAO-induced alterations were
also seen in the contralateral side of the brain. The changes of
insulin signaling in the cerebral cortex were somewhat similar but
not identical to those seen in the hippocampus. Taken together,
these results indicate that CCH results in alterations in insulin
signaling.
CCH LEADS TO NEURONAL DEGENERATION
To investigate whether CCH for 2.5 months causes neuronal
degeneration, we stained the mouse brain frozen sections with
Fluoro-Jade that labels degenerating neurons with green ﬂuores-
cence. Overall, there were very few Fluoro-Jade positive neurons
in the control mouse brain. We did not observe widespread
Fluoro-Jade positive staining throughout the brain with CCH
either. However, we found a slight increase in the number of
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FIGURE 7 | Effects of CCH on neuronal degeneration. Representative
microphotographs of Fluoro-Jade stainining of cerebral cortex and dentate
gyrus sections of mice 2.5 months after sham or UCCAO surgery (A). The
Fluoro-Jade positive neurons were then quantiﬁed by using the Image J
software, and the data are presented as mean ± SEM (n = 6/group) (B).
Coexistence of hyperphosphorylated tau (detected using antibody against
pS262) and Fluoro-Jade positive neurons was seen in adjacent
sections (C).*p < 0.05 vs. sham group.
Fluoro-Jade positive neurons in the ipsilateral cerebral cortex and
hippocampus of the UCCAO brains, and this increase was most
obviously seen in the granule cells of the crest of the dentate
gyrus (Figure 7A). Quantiﬁcation of the Fluoro-Jade positive
neurons showed a signiﬁcant increase in the ipsilateral side of
cerebral cortex and dentate gyrus (Figure 7B). These results indi-
cate that CCH for 2.5 months induces mild neurodegeneration
and the dentate gyrus is the most sensitive area for CCH-induced
neurodegeneration.
To investigate whether the CCH-induced chronic neurodegen-
eration is associated with tau hyperphosphorylation, we stained
the adjacent brain sections with anti-pS262 that detects tau phos-
phorylated at Ser 262 and this immunoreactivity was increased
dramatically in the CCH brains (Figure 4). We found a marked
increase in anti-pS262 staining in neurons that are Fluoro-Jade
positive in the dentate gyrus (Figure 7C). These observations
suggest that the CCH-induced neuronal degeneration might
be caused or associated with abnormal hyperphosphorylation
of tau.
DISCUSSION
The human brain constitutes only ∼2% of the body’s mass, but
it receives 15–20% of the body’s blood supply and accounts
for up to 50% of the total body glucose utilization under the
basal condition (Peters, 2011). Normal brain function requires
a steady blood supply to maintain the stable energy state carry-
ing out all of its cellular and molecular needs. When the blood
supply to the brain becomes suboptimal for a long period of
time, clinical implications involving chronic hypoperfusion and
a variety of brain changes may occur. A series of experiments
designed to mimic CCH have been achieved by permanent or
reversible occlusion of two or three major vessels supplying the
brain in rats. UCCAO is one of the approaches to produce
CCH in mice and results in a 35–55% decrease of the ipsilat-
eral cortical perfusion, as detected 28 days after the UCCAO
surgery (Kitagawa et al., 2005). This model is thus ideal to inves-
tigate the contribution of CCH to cognitive deﬁcits and AD
pathology.
Glucose is the primary source of fuel for energy-demanding
activities in mammalian brain. Together with oxygen, glucose is
delivered by the circulation for the metabolic chores that keep
brain cells healthy and functioning (Erecin´ska and Silver, 1989;
Qutub and Hunt, 2005). The transport of glucose from blood
into neurons requires GLUTs. Glucose is ﬁrst transported from
bloodstream into extracellular space through GLUT1, which is
highly expressed in the endothelial cells of the blood–brain barrier,
Frontiers in Aging Neuroscience www.frontiersin.org February 2014 | Volume 6 | Article 10 | 12
Zhao et al. Chronic cerebral hypoperfusion in neurodegeneration
then further transported into neurons through neuronal GLUT3.
As a response to the energy-demand following cerebral hypop-
erfusion, the expression and activity of these glucose transporters
increase (Vannucci et al., 1997, 1998;Yu et al., 2008). This compen-
sation is mainly mediated by the transcription factor HIF-1 that
responds to hypoxia (Singh et al., 2012). TIGAR is a recently dis-
covered enzyme that primarily functions as a regulator of glucose
metabolism in the cell (Bensaad et al., 2006). Its expression is also
elevated in responding to cardiac ischemia (Kimata et al., 2010).
In the present study, we observed signiﬁcant increases in the levels
of HIF-1β, TIGAR, GLUT1, and GLUT3 in the ipsilateral side of
the brain after UCCAO. These observations are consistent with the
previous reports and help conﬁrm the success of achieving CCH
in the UCCAO mice.
In the present study by using the well-established UCCAO on
4.5–6 month old mice, we demonstrated that CCH caused anxiety,
motor function deﬁcits, and mild impairment of cognitive func-
tions. These ﬁndings provide experimental evidence that CCH
alone can lead to memory deﬁcits. CCH for more than one month
resulted in only mild cognitive deﬁcits, indicating a large reserved
capacity of the brain. Pimentel-Coelho et al. (2013) performed
UCCAO on 4-month-old mice and did not ﬁnd any cognitive
deﬁcits tested by using T-water maze task ﬁve weeks after UCCAO,
but the same approach led to spatial learning impairments inAPP-
swe/PS1 mice (Pimentel-Coelho et al., 2013). Our observations
that mild cognitive impairment of the CCH mice was detectable
only in the more sensitive reversal MWM, but not in the original
MWM, are consistent with the above report. CCH’s initiation of
cognitive impairment may be aggravated by other insults (such
as overexpression of APPswe/PS1). A synergistic effects between
overexpression of mutatedAPP and CCH on learning impairment
in a mouse model, which over-expresses humanAPP bearing both
the Swedish and Indiana mutations (APPSw/Ind-Tg mice), has
been observed previously (Yamada et al., 2011). It is interesting
for future studies to investigate the impact of CCH for a much
longer time on cognitive function since many individuals could
have cerebrovascular deﬁcits years before the onset of memory
loss in AD.
To investigate the possible molecular mechanisms that might
underlie the CCH-induced cognitive impairment, we further
investigated several AD-related molecules and pathways in the
CCH mouse brain. Because O-GlcNAcylation is a sensor of intra-
cellular glucose metabolism (Zachara and Hart, 2004) and is
expected to be decreased under the hypoperfusion condition, we
investigated protein O-GlcNAcylation. We found a signiﬁcant
decrease in the O-GlcNAcylation level in both the cortex and
the hippocampus of the ipsilateral hemisphere of the UCCAO.
These results indicate that the compensative increase in GLUT1
and GLUT3 might fail to compensate the intracellular glucose to
the normal level. The reduction of O-GlcNAcylation level may
result from a reduction of the intracellular level of UDP-GlcNAc,
which is the donor for protein O-GlcNAcylation and is also the
major activator of OGT activity, because UDP-GlcNAc is synthe-
sized from glucose metabolism HBP. As we also found a reduction
of OGT level in the hippocampus of the CCH brain, this reduction
might also contribute to the decrease of O-GlcNAcylation in the
hippocampus of the CCH mice.
It has been demonstrated that abnormal hyperphosphoryla-
tion of tau is crucial to neurodegeneration in AD and prob-
ably also in other tauopathies (Gong and Iqbal, 2008; Iqbal
et al., 2013). Tau hyperphosphorylation can be promoted by
several factors. One of these factors is decreased brain glucose
metabolism through down-regulation of tau O-GlcNAcylation
because the latter regulates tau phosphorylation inversely (Liu
et al., 2004, 2009; Li et al., 2006). We therefore studied site-speciﬁc
tau phosphorylation and found elevated tau phosphorylation at
two sites (Thr212 and Ser262) in the cerebral cortex and six
sites (Ser199, Thr205, Thr212, Ser214, Thr231, and Ser262)
among the eight phosphorylation sites studied in the hippocam-
pus in mice after CCH. Elevated tau phosphorylation at more
sites in the hippocampus than in the cortex suggests that the
hippocampus is more vulnerable to CCH-induced tau hyper-
phosphorylation. Higher vulnerability of the hippocampus to
fasting-induced reduction of O-GlcNAcylation and elevation of
tau phosphorylation than the cerebral cortex were also seen pre-
viously (Li et al., 2006). This differentiative vulnerability of tau
hyperphosphorylation is fully consistent to the fact that the hip-
pocampus is more vulnerable to neurodegeneration than the
cerebral cortex in AD, further supporting the role of CCH in
the development of AD. Taken together, these ﬁndings suggest
that CCH leads to decreased O-GlcNAcylation and then hyper-
phosphorylation of tau. Abnormally hyperphosphorylated tau
might also contribute to the increased anxiety observed in the
CCH mice since a link between anxiety-related behavior and
tau hyperphosphorylation was reported previously (Pristera et al.,
2013).
It is surprising that the increased tau phosphorylation was
also seen at the contralateral side, where O-GlcNAcylation was
not decreased, in the UCCAO mice. These observations suggest
that an additional mechanism might be involved in tau hyper-
phosphorylation at the contralateral side of the UCCAO mice.
Alternatively, it is possible that the mice had produced sufﬁcient
cross circulation between two hemispheres during the 2.5 month
period after UCCAO leading to a signiﬁcant reduction of the per-
fusion in the contralateral hemisphere due to blood steal, although
this phenomenon was not seen 28 days after UCCAO (Kitagawa
et al., 2005). This possibility is supported by our observations of
increased GLUT1 level in the contralateral cortex and a clear ten-
dency of increased GLUT3 level in the contralateral cortex and
hippocampus. Alterations of synaptic proteins and some insulin
signaling proteins, as well as slight increase in the number of
degenerative neurons, were also seen in the contralateral side of
the mouse brains after UCCAO.
Synapses are the structural basis of neural connection, neu-
ral plasticity and cognitive function. The clinical symptoms of AD
correlate highly to the synaptic loss in the brain (Scheff et al., 2011).
Elevated levels of synaptic proteins, such as of synaptophysin, syn-
taxin, and SNAP-25, are observed in human brains with Braak
stages 3 and 4 (Mukaetova-Ladinska et al., 2000), whereas loss
of synaptic proteins is a relatively late phenomenon in AD brain,
occurring well after the onset of clinically detectable dementia and
the appearance of Aβ plaques and NTFs (Mukaetova-Ladinska
et al., 2000). The present study also showed altered levels of synap-
tic proteins, including increased pre-synaptic protein synapsin and
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post-synaptic protein PSD95, as well as decreased pre-synaptic
protein synaptophysin, in the cerebral cortex and/or the hip-
pocampus of the CCH mice 2.5 months after UCCAO. These
alterations of the synaptic proteins suggest alterations of synaptic
vesicle integrity and functions and might underlie the molecular
basis of the mild cognitive deﬁcits of the CCH mice. Decreased
level of synaptophysin and alterations of synaptic ultrastructure
in the CA1 area of the hippocampus have been observed in rat
brains after chronic cerebrovascular hypoperfusion (Wang et al.,
2010).
Recent studies have established that brain insulin signaling
plays an important role in the regulation of neuronal activ-
ity and neural plasticity (van der Heide et al., 2006; Reagan,
2007). Dysregulation of brain insulin signaling has been reported
in AD (Frolich et al., 1999; Rivera et al., 2005; Steen et al.,
2005; Liu et al., 2011). Various changes of the insulin signal-
ing pathway are seen in different models of neurodegenerative
disorders (Pedersen and Flynn, 2004; Chen et al., 2012, 2013).
The different changes of insulin signaling in AD and in these
models might represent a diversity of insults, which might
ultimately contribute to cognitive impairment. In the present
study, majority of the alterations of the insulin signaling path-
way was increases rather than decreases, which might represent
possible compensation in response to CCH. These compen-
sative changes resulted in a marked increase in the inhibitory
Ser9 phosphorylation of GSK-3β and thus a marked inhibition
of its kinase activity. However, the GSK-3β phosphorylation
sites of tau were hyperphosphorylated rather than hypophos-
phorylated in the CCH mouse brains, suggesting that other
opposing factors, such as reduction of O-GlcNAcylation and
probably activation of some other tau kinases, had counteracted
the effect of GSK-3β inhibition on tau phosphorylation after
CCH.
No detectable ischemia or cell death were observed previously
in the brains of 3–4 months old mice after UCCAO (Kitagawa
et al., 2005; Pimentel-Coelho et al., 2013). In the present study,
however, we found degenerative neurons by using Fluoro-Jade
staining in the brains, especially in the granule neurons of the
dentate gyrus, of the brains in 7–8.5 months old CCH mice.
Furthermore, these degenerative neurons were ﬁlled with hyper-
phosphorylated tau, suggesting that neurodegeneration might be
attributed to tau phosphorylation in the CCH mouse brains. As
the granule neurons of the dentate gyrus receive inputs from
the entorhinal cortex through the perforant pathway and send
signals to the CA3 pyramidal neurons through the mossy ﬁber
pathway, which makes the critical pathways for memory pro-
cessing and recording, neuronal degeneration in these areas,
together with the synaptic deﬁcits,might underlie the basis of mild
memory impairments observed in the CCH mice in the present
study.
In conclusion, the present study shows that CCH induced
by UCCAO decreased the protein O-GlcNAcylation, increased
tau phosphorylation, dysregulated synaptic proteins and brain
insulin signaling, and caused mild cognitive impairment.
These studies provide experimental evidence showing the pos-
sible mechanisms by which CCH can contribute to cognitive
impairment and AD probably through reduction of protein
O-GlcNAcylation, hyperphosphorylation of tau, dysregulated
synaptic plasticity and neural degeneration in the brain. These
ﬁndings also provide a possible mechanistic linkage between AD
and VaD.
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